Isolated cytochrome c oxidase (complex IV) deficiency is one of the most frequent respiratory chain defects in humans and is usually caused by mutations in proteins required for assembly of the complex. Mutations in nuclear-encoded structural subunits are very rare. In a patient with Leigh-like syndrome presenting with leukodystrophy and severe epilepsy, we identified a homozygous splice site mutation in COX8A, which codes for the ubiquitously expressed isoform of subunit VIII, the smallest nuclearencoded subunit of complex IV. The mutation, affecting the last nucleotide of intron 1, leads to aberrant splicing, a frame-shift in the highly conserved exon 2, and decreased amount of the COX8A transcript. The loss of the wild-type COX8A protein severely impairs the stability of the entire cytochrome c oxidase enzyme complex and manifests in isolated complex IV deficiency in skeletal muscle and fibroblasts, similar to the frequent c.845_846delCT mutation in the assembly factor SURF1 gene. Stability and activity of complex IV could be rescued in the patient's fibroblasts by lentiviral expression of wild-type COX8A. Our findings demonstrate that COX8A is indispensable for function of human complex IV and its mutation causes human disease.
Introduction
Cytochrome c oxidase (COX) is the terminal enzyme complex of the respiratory chain and catalyses the transfer of electrons from cytochrome c to oxygen coupled to proton pumping from the mitochondrial matrix to the intermembrane space. Isolated COX deficiency (MIM 220110), one of the most frequent respiratory chain defects in humans, is usually caused by mutations in genes coding for proteins required for translation or maturation of mitochondrialencoded COX subunits or assembly of the complex (Soto et al., 2012) . Mutations affecting structural subunits of complex IV have been very rarely described to be associated with disease. To date, mutations in four structural subunits of COX [COX6A1 (Tamiya et al., 2014) , COX6B1 (Massa et al., 2008; Abdulhag et al., 2015) , COX4I2 (Shteyer et al., 2009) , and COX7B (Indrieri et al., 2012) ] have been reported. Furthermore, mutations in NDUFA4 (Pitceathly et al., 2013) , a gene that encodes a protein that was previously assigned to complex I, but recently claimed to be an additional COX subunit, also leads to a mitochondrial disease. Here, we describe a patient with a multisystemic Leigh-like syndrome associated with severe isolated COX deficiency in skeletal muscle and fibroblasts due to a homozygous splice site mutation in COX8A. This mutation leads to a loss of functional COX8A protein. Our data show that this small nuclear-encoded structural subunit is indispensable for stability and activity of the cytochrome c oxidase complex.
Materials and methods

Patients
The female COX8A patient was the child of parents of Turkish origin. Consanguinity was not known, but was suggested by genetic data. She was born after an uneventful pregnancy and delivery at normal gestational age. A congenital scoliosis with thoracolumbar kyphosis and bilateral pes planovalgus were present at birth. Primary developmental delay and primary pulmonary hypertension were diagnosed at the age of 6 months. At the age of 4-5 years, a cachectic appearance with malnutrition and recurrent vomiting was evident, and a percutaneous gastrointestinal feeding tube was inserted. At the age of 8 years, the girl presented with a febrile state due to pneumonia and urinary tract infection, which resulted in the first manifestation of focal and generalized epileptic tonic-clonic seizures and a severe metabolic crisis with lactic acidosis. Further clinical phenotyping and diagnostic procedures showed serious psychomotor retardation, a short stature, microcephalus, enophthalmus, proximal muscular hypotonia, distal spasticity of upper and lower limbs, weak deep tendon reflexes, and absent extensor plantar responses. At the age of 10 years, a dislocation of both hips was diagnosed. Meanwhile, the patient was non-ambulatory and wheelchairbound. Her severe epilepsy presented with tonic-clonic, myoclonic, and atonic seizures and only partly responded to various antiepileptic drug treatment regimens including levetiracetam, oxcarbazepine, and sultiame. Pneumonia with sepsis manifested at the age of 12 years resulting in a serious metabolic crisis and cardiorespiratory failure. The patient died after several weeks of intensive care unit treatment after unsuccessful cardiopulmonary resuscitation at the age of 12.5 years.
Diagnostic work-up at the age of 8 years showed pathological EEG changes with generalized slowing and continuous multifocal spike-and-wave activity. Elevated lactate levels were present in the CSF (max. 11.4 mmol/l, normal values 52) and peripheral blood (max. 6.2 mmol/l, normal values 51.6). Metabolic screening of the urine and CSF showed elevated lactate and citric acid cycle metabolite levels, as well as increased glycine and alanine levels. Ophthalmological examinations detected a pigmentary retinopathy.
Brain MRI at the age of 8 years (Fig. 1A) showed a leftsided small lacunar thalamic lesion without further basal ganglia or cortical signal alterations, signal hyperintensities in T 2 -weighted sequences in the right cerebellar hemisphere. Diffusion-weighted imaging revealed extensive and symmetric areas of restricted diffusion in the white matter that were first interpreted as encephalitis or metabolic encephalopathy. A subsequent brain MRI at the age of 12 years (Fig. 1B) showed a progressive and extent atrophy especially of the white matter with white matter signal changes in T 2 -weighted sequences that were most pronounced in periventricular areas, cerebellar hemispheres, and parietooccipital lobes. A consecutive biventricular ex vacuo enlargement and cystic defects with parietooccipital predominance were also detected.
SURF1-deficient fibroblasts and the corresponding skeletal muscle biopsy sample were from a 3-year-old girl of Saudi Arabian origin harbouring the homozygous c.845_846delCT mutation in the SURF1 gene. Control muscle and skin specimens were obtained from 28 patients who underwent a muscle biopsy for diagnosis of neuromuscular symptoms but were ultimately deemed to be normal by means of combined clinical, electrophysiological, and histological criteria. Written informed consent was obtained from the parents of the patients and all investigations were carried out according to the guidelines of the Ethical committee of the University Bonn Medical Centre.
Histological and immunohistological investigations
Histological investigations of open skeletal muscle biopsies (vastus lateralis muscles) of the patients were performed according to protocols described by Dubowitz and Sewry (2007) . For immunohistochemical visualization of respiratory chain enzyme complexes, an antibody against the 15 kDa subunit of complex I (NDUFS5; Molecular Probes, A31856, clone 17G3) and an antibody against the subunit 1 of COX (MT-CO1; Molecular Probes, A6403, clone 1D6) were used. To determine the efficiency of viral transduction in fibroblasts, we used an anti-DDK antibody from OriGene Technologies.
Cell culture conditions
Fibroblasts from 5 Â 5 mm skin biopsies of both patients were cultivated in high-glucose (4.5 g/l) Dulbecco's modified Eagle medium with pyruvate and glutamine (PAA Laboratories) supplemented with 10% foetal calf serum, 100 U/ml penicillin, 100 U/ml streptomycin, and 50 mg/l uridine in a 6.5% CO 2 atmosphere at 37 C. Cells were harvested after passage 11 or 12 and suspended in phosphate-buffered saline.
Enzyme activity, respiration measurements and blue native polyacrylamide gel electrophoresis
The activity of citrate synthase, rotenone-sensitive NADH:CoQ 1 oxidoreductase, and COX was determined by standard methods (Wiedemann et al., 2000) . The details on the performed biochemical assays are outlined in the Supplementary material.
DNA and RNA samples, molecular biology techniques and lentiviral rescue of COX8A Genomic DNA was isolated from 10 ml aliquots of EDTAanticoagulated blood by a salting-out technique (Miller et al., 1988) . Total fibroblast RNA was obtained by disrupting cells in TRIzol Õ Reagent (Life Technologies) followed by isolation of the RNA with the RNeasy Õ MiniKit (Qiagen). Tissue-specific expression of COX8A and COX8C was investigated using the Human Multiple Tissue cDNA Panel 1 from Clontech Laboratories, Inc., and FirstChoice Õ Human Brain Total RNA from testis (Ambion). Complementary DNA was produced from RNA templates with the iScript TM Select cDNA synthesis kit (Bio-Rad) using random primers for reverse transcription. The details on polymerase chain reaction (PCR) amplification, whole exome sequencing and lentiviral rescues of COX8A are outlined in the Supplementary material.
Statistical analysis
The results are presented as mean AE standard deviation (SD). Significant changes were assessed by Student's t-test, with P 5 0.05 as the level of significance.
Results
Biochemical analysis of skeletal muscle and fibroblast homogenates of a patient with microcephalus, serious psychomotor retardation and severe epilepsy (Supplementary  Tables 1 and 2) showed an isolated deficiency of COX activity in both tissues. A uniformly distributed weak COX staining was visible in the skeletal muscle biopsy (Fig. 2 , middle), even more severe as observed for a patient with a homozygous frame shift mutation in SURF1, an assembly factor of COX (Fig. 2) . The respiration activities, determined in digitonin-permeabilized fibroblasts (Supplementary Table  3) , also support the isolated COX deficiency in the COX8A patient, rather similar to the data obtained from a patient harbouring the SURF1 mutation. While the endogenous respiration activities were nearly unaltered, the ADP supported respiration with all tested substrate combinations were approximately two times lower than the corresponding control values. Moreover, the maximal respiratory activity showed an elevated sensitivity to the COX inhibitor azide, corresponding to an increased flux control coefficient of cytochrome c oxidase (Kuznetsov et al., 1997) . Whole exome sequencing of the index patient revealed rare homozygous missense variants in 19 genes (Supplementary Table 4 ) and one splice site mutation, among which only the c.115-1G4C splice acceptor site mutation in COX8A (Fig. 3A) could be attributed to a mitochondrial protein (Mitocarta). Among the detected missense mutations only the BCAN p.G720S mutation reached a CADD score 427, but was not considered being relevant for the disease because brevican-deficient mice show no obvious phenotypic abnormality (Brakebusch et al., 2002) . To confirm aberrant splicing that was predicted by the position of the COX8A mutation, we amplified the cDNA of a large part of the COX8A transcript with primers located in the 5' and 3'-end untranslated regions. To detect, in parallel, the transcript of the other human COX8 gene, COX8C, we performed multiplex PCR (Fig. 3B) . In line with the reported Figure 2 Decreased COX activity in skeletal muscle due to COX8A and SURF1 mutations. Muscle histochemistry from a control subject (A, D and G), the COX8A patient (B, E and H) and a patient harbouring the homozygous c.845_846delCT SURF1 mutation (C, F and I). ubiquitous expression of COX8A, its transcript was detectable in all investigated tissues, while the COX8C transcript was only observed in pancreas, lung, placenta, and testis. A shorter COX8A-specific PCR product was present in fibroblasts of the COX8A patient (Fig. 3B, asterisk) , indicating aberrant splicing. Quantitative measurements by real-time PCR (normalized to the transcript abundance of PMPCA, the gene for a housekeeping protein, mitochondrial processing peptidase) showed that the amount of the aberrant splice product was $20-fold lower than the amount of the normal transcript in controls (patient, 0.089 AE 0.006; control, 1.74 AE 0.14). Despite the lack of normal COX8A transcript in the patient's sample, no change of the COX8C transcripts was noted (patient, 3.5 Â 10 À4 AE 0.2 Â 10 À4 ; control, 4.9 Â 10 À4 AE 0.4 Â 10
À4
; values normalized to PMPCA). COX8A splice acceptor site mutation by conventional Sanger sequencing. The disrupted acceptor motive is indicated by the dashed box. (B) Multiplex PCR detection of COX8A and COX8C expression in different tissues. The upper band represents the COX8A transcript, the lower band the COX8C transcript. The asterisk indicates the shorter COX8A transcript in the fibroblasts of the COX8A patient. From left to right: molecular weight marker, brain, liver, skeletal muscle, kidney, pancreas, lung, placenta, testis, heart, fibroblasts from the COX8A patient, control fibroblasts, molecular weight marker. (C) Sequence of the COX8A cDNA from the index patient (mut, upper sequence) and of a control (wt, lower sequence). The loss of 49 nucleotides by aberrant splicing at a downstream cryptic AG splice acceptor site is indicated.
To determine the exact nature of the aberrant splicing, we sequenced the transcript from the patient and compared it to a COX8A transcript sequence from a control (Fig. 3C) . As the c.115-1G4C splice site mutation disrupted the regular AG splice acceptor site at the end of intron 1, aberrant splicing occurred at a cryptic AG splice acceptor site in exon 2, which led to the removal of 49 nucleotides. This deletion results in a shift of the reading frame for the entire exon 2 (Fig. 3C) . As exon 2 encodes the 31 C-terminal amino acids of the 44 amino acid-long mature peptide, the translated mutant protein is very likely not functional. This and the low abundance of the mutated transcript explain the severe functional effect leading to only $10% wild-type COX activity in skeletal muscle and fibroblasts.
For several small structural subunits of COX, it has been reported that their loss resulted in decreased amounts of the entire complex (Massa et al., 2008; Indrieri et al., 2012; Abdulhag et al., 2015) . As COX8A is the smallest structural subunit of COX, we were interested to see whether this was also the case for COX8A. To this end, we determined the steady-state amounts of the fully assembled COX complex in skeletal muscle mitochondrial fractions by blue native polyacrylamide gel electrophoresis (PAGE) (Fig. 4A) . A marked reduction of the COX complex in the absence of any detectable subcomplexes was observed with antibodies against MT-CO1, COX4 and COX5A at comparable immunoreactivity against SDHA. As the small nuclear subunits are added to the complex at the last stage of its assembly (Mick et al., 2011) , this indicates that a severely impaired stability of the fully assembled COX complex in the absence of functional COX8A protein is the molecular cause for the reduced enzymatic activity in the index patient.
To verify the causative role of the loss of COX8A in the observed isolated COX deficiency, we used a lentiviral system in the patient's fibroblasts to express the wild-type COX8A protein C-terminally tagged with myc-DDK. At maximal virus load, a $60% transduction efficiency was observed, as estimated by DDK immunoreactivity. Opposite to the sample transfected with the empty virus (Fig. 4D) , in the COX8A-transduced sample, a high proportion of fibroblasts showed a typical mitochondrial pattern of MT-CO1 immunoreactivity (Fig. 4G) , and this co-localized with the NDUFS5 (complex I) signal (Fig. 4H) . The proportion of MT-CO1 immunoreactive fibroblasts strongly correlated with that of DDK-positive fibroblasts in different experiments with varying virus amounts (Fig. 4B) . In functional activity assays on fibroblast homogenates, viral expression of COX8A caused a substantial increase of COX activity reaching almost 67% of the control activity and correlated with the percentage of transduced cells and the percentage of MT-CO1 immunoreactive cells (Fig. 4B) .
Discussion
The nuclear-encoded subunits of COX complex are small and surround the catalytic core of the enzyme that comprises three mitochondrial-encoded subunits (Capaldi, 1990) . Their number varies in different organisms. As the bacterial enzyme with only the three catalytic subunits is fully functional, the precise roles of the nuclear subunits in the eukaryotic enzyme are not well understood. However, it is believed that they are involved in the regulation and assembly of the complex (Mick et al., 2011) . Accordingly, isolated COX deficiency underlying human disease has been reported to be associated with pathogenic mutations in some of these nuclear genes. The spectrum of phenotypes described in deficiencies of structural subunits of COX is heterogeneous. A COX6A1 mutation was found to cause axonal or mixed form of Charcot-Marie-Tooth disease (Tamiya et al., 2014) , mutated COX4I2 leads to exocrine pancreatic insufficiency and dyserythropoetic anaemia (Shteyer et al., 2009) , and COX7B deficiency manifests in microphthalmia with linear skin lesions (Indrieri et al., 2012) . The phenotype of the COX8A patient reported here, a Leigh-like syndrome associated with leukodystrophy and severe epilepsy, most closely resembles the severe encephalopathy described for mutations of the NDUFA4 (Pitceathly et al., 2013) and COX6B1 (Massa et al., 2008; Abdulhag et al., 2015) genes, although the residual activities of COX in skeletal muscle and fibroblasts in our patient were considerably lower.
The COX8A protein is the smallest subunit of the COX complex-the mature human protein contains only 44 amino acids. Very little is known about its precise function. It has been presumably added to the entire COX complex before the radiation of animals (Pierron et al., 2012) . Mammals are known to express three COX VIII isoforms (COX8A, COX8B and COX8C) although COX8B has been silenced in catarrhines, including primates (Goldberg et al., 2003) . Interestingly, on loss of COX8A we did not observe any adaptive change in expression of the still remaining isoform COX8C or even an adaptive proliferation of mitochondria, which is frequently seen in mitochondrial DNA disorders (Sebastiani et al., 2007) .
The following functional data are consistent with this mutation to be the cause of the isolated COX deficiency and highlight the role of the COX8A subunit for the stability of COX. First, on the transcript level we detected in patient fibroblasts a shorter COX8A mRNA. The shorter mRNA molecule is the result of a deletion of 49 nucleotides from exon 2, due to aberrant splicing at a downstream cryptic AG splice acceptor site. This results in a shift of the reading frame for the retained remainder of exon 2 (p.Glu39Argfs*27). Presumably due to the lower efficiency of splicing at the new AG splice acceptor site [the maximum entropy score (Yeo et al., 2004 ) is 7.87 at the new site as opposed to 10.03 at the wild-type site] the amount of mutated COX8A transcripts was $20-fold reduced in comparison to wild-type transcripts in controls. Second, on the protein level the mutation led to a dramatic decrease of stability of the fully assembled COX complex, as detected in blue native PAGE of mitochondrial fractions from skeletal muscle and by largely reduced immunoreactivity of fibroblasts with antibodies against COX subunit 1. Third, by lentiviral transduction of patient fibroblasts with wild-type COX8A we were able to rescue both COX complex stability and activity.
Summarizing, with our data we were able to show that the ubiquitously expressed small COX8A protein, which is present in the animal COX complex only, is not an activity regulating accessory protein, but is essential for the stability of the entire human COX complex.
